Validation of the multiplex ligation-dependent probe amplification (MLPA) technique for the determination of HER2 gene amplification in breast cancer

Diagnostic Molecular Pathology

Volumn 20, Issue 1, 2011, Pages 11-17

  Farshid, Gelareh ^a   Cheetham, Glenice ^b   Davies, Ruth ^a   Moore, Sarah ^b   Rudzki, Zbigniew ^b  

^a Division of Surgical Pathology   (Australia)

^b BreastScreen   (Australia)

Author keywords

breast cancer; HER2; in situ hybridization; PCR

Indexed keywords

ARTICLE; BREAST CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DOSAGE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; ONCOGENE NEU; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79952147118     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3181ed7832     Document Type: Article

References (16)

1. Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287-5312.
2. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131:18-43. (Pubitemid 46174133)
3. Van de Vijver M, Bilous M, Hanna W, et al. Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study. Breast Cancer Res. 2007;9:R68.
4. Bossard C, Bieche I, Le Doussal V, et al. Real-time RT-PCR: a complementary method to detect HER-2 status in breast carcinoma. Anticancer Res. 2005;25:4679-4683. (Pubitemid 41729530)
5. Ginestier C, Charafe-Jauffret E, Penault-Llorca F, et al. Comparative multi-methodological measurement of ERBB2 status in breast cancer. J Pathol. 2004;202:286-298. (Pubitemid 38325237)
6. Gjerdrum LM, Sorensen BS, Kjeldsen E, et al. Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis. J Mol Diagn. 2004;6:42-51. (Pubitemid 38208344)
7. Vinatzer U, Dampier B, Streubel B, et al. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization. Clin Cancer Res. 2005;11:8348-8357. (Pubitemid 41746947)
8. Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30:e57.
9. Jankowski S, Currie-Fraser E, Xu L, et al. Multiplex ligationdependent probe amplification analysis on capillary electrophoresis instruments for a rapid gene copy number study. J Biomol Tech. 2008;19:238-243.
10. Kozlowski P, Jasinska AJ, Kwiatkowski DJ. New applications and developments in the use of multiplex ligation-dependent probe amplification. Electrophoresis. 2008;29:4627-4636.
11. White SJ, Breuning MH, den Dunnen JT. Detecting copy number changes in genomic DNA: MAPH and MLPA. Methods Cell Biol. 2004;75:751-768.
12. Moerland E, Van Hezik RL, Van der Aa TC, et al. Detection of HER2 amplification in breast carcinomas: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH) combined with automated spot counting. Cell Oncol. 2006;28:151-159. (Pubitemid 44427398)
13. Purnomosari D, Aryandono T, Setiaji K, et al. Comparison of multiplex ligation dependent probe amplification to immunohistochemistry for assessing HER-2/neu amplification in invasive breast cancer. Biotech Histochem. 2006;81:79-85.
14. Moelans CB, De Weger RA, Van Blokland MT, et al. HER-2/ neu amplification testing in breast cancer by multiplex ligation- dependent probe amplification in comparison with immunohistochemistry and in situ hybridization. Cell Oncol. 2009;31: 1-10.
15. Gonzalez JR, Carrasco JL, Armengol L, et al. Probe-specific mixedmodel approach to detect copy number differences using multiplex ligation-dependent probe amplification (MLPA). BMC Bioinformatics. 2008;9:261.
16. Moelans CB, De Weger RA, Ezendam C, et al. HER-2/neu amplification testing in breast cancer by multiplex ligationdependent probe amplification: influence of manual- and laser microdissection. BMC Cancer. 2009;9:4.